Skip to main content
Top
Published in: Annals of Intensive Care 1/2018

Open Access 01-12-2018 | Research

Inflammatory and coagulatory parameters linked to survival in critically ill children with sepsis

Authors: Christian Niederwanger, Mirjam Bachler, Tobias Hell, Caroline Linhart, Andreas Entenmann, Agnes Balog, Katharina Auer, Petra Innerhofer

Published in: Annals of Intensive Care | Issue 1/2018

Login to get access

Abstract

Background

Sepsis is associated with a deflection of inflammatory and coagulative parameters, since some clotting factors are known to be involved in the host’s defense against infection and inflammation. These parameters could play a crucial role in the course of sepsis and be used as prognostic markers in critically ill children.

Methods

A total of 250 critically ill pediatric patients diagnosed with sepsis were retrospectively analyzed to identify routinely measured predictors for in-hospital mortality at the peak level of C-reactive protein. Those parameters entered multivariate logistic regression analysis as well as a decision tree for survival.

Results

Multivariate logistic regression analysis revealed fibrinogen, platelets and activated partial thromboplastin time (aPTT) at the peak level of C-reactive protein to be predictors for survival (p = 0.03, p = 0.01 and p = 0.02, respectively). An increase in fibrinogen and platelets is linked to survival, whereas an aPTT prolongation is associated with higher mortality; adjusted odds ratios (95% CI) for an increase of 100 mg/dl in fibrinogen are 1.35 (1.04–1.82) per 50 G/l platelets 1.94 (1.3–3.29) and 0.83 (0.69–0.96) for an aPTT prolongation of 10 s. Decision tree analysis shows that a fibrinogen level below 192 mg/dl (90.9% vs. 13% mortality) is most distinctive in non-survivors.

Conclusions

High levels of fibrinogen and platelets as well as a non-overshooting aPTT are associated with a higher survival rate in pediatric patients with diagnosed sepsis. In particular, hypofibrinogenemia is distinctive for a high mortality rate in septic critically ill children.
Appendix
Available only for authorised users
Literature
1.
go back to reference Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2–8.CrossRef Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2–8.CrossRef
2.
go back to reference Randolph AG, McCulloh RJ. Pediatric sepsis: important considerations for diagnosing and managing severe infections in infants, children, and adolescents. Virulence. 2014;5(1):179–89.CrossRef Randolph AG, McCulloh RJ. Pediatric sepsis: important considerations for diagnosing and managing severe infections in infants, children, and adolescents. Virulence. 2014;5(1):179–89.CrossRef
3.
go back to reference Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS. Trends in the epidemiology of pediatric severe sepsis*. Pediatr Crit Care Med. 2013;14(7):686–93.CrossRef Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS. Trends in the epidemiology of pediatric severe sepsis*. Pediatr Crit Care Med. 2013;14(7):686–93.CrossRef
4.
go back to reference Sokou R, Giallouros G, Konstantinidi A, Pantavou K, Nikolopoulos G, Bonovas S, et al. Thromboelastometry for diagnosis of neonatal sepsis-associated coagulopathy: an observational study. Eur J Pediatr. 2018;177(3):355–62.CrossRef Sokou R, Giallouros G, Konstantinidi A, Pantavou K, Nikolopoulos G, Bonovas S, et al. Thromboelastometry for diagnosis of neonatal sepsis-associated coagulopathy: an observational study. Eur J Pediatr. 2018;177(3):355–62.CrossRef
5.
go back to reference van der Poll T, van Deventer SJ. Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am. 1999;13(2):413–26.CrossRef van der Poll T, van Deventer SJ. Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am. 1999;13(2):413–26.CrossRef
6.
go back to reference Reddy RC, Chen GH, Tekchandani PK, Standiford TJ. Sepsis-induced immunosuppression. Immunol Res. 2001;24(3):273–87.CrossRef Reddy RC, Chen GH, Tekchandani PK, Standiford TJ. Sepsis-induced immunosuppression. Immunol Res. 2001;24(3):273–87.CrossRef
7.
go back to reference Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31(4):1250–6.CrossRef Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31(4):1250–6.CrossRef
8.
go back to reference Schneider HG, Lam QT. Procalcitonin for the clinical laboratory: a review. Pathology. 2007;39(4):383–90.CrossRef Schneider HG, Lam QT. Procalcitonin for the clinical laboratory: a review. Pathology. 2007;39(4):383–90.CrossRef
9.
go back to reference Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 2004;8(4):R234–42.CrossRef Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 2004;8(4):R234–42.CrossRef
10.
go back to reference Clec’h C, Ferriere F, Karoubi P, Fosse JP, Cupa M, Hoang P, et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med. 2004;32(5):1166–9.CrossRef Clec’h C, Ferriere F, Karoubi P, Fosse JP, Cupa M, Hoang P, et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med. 2004;32(5):1166–9.CrossRef
11.
go back to reference Chiesa C, Natale F, Pascone R, Osborn JF, Pacifico L, Bonci E, et al. C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. Clin Chim Acta. 2011;412(11):1053–9.CrossRef Chiesa C, Natale F, Pascone R, Osborn JF, Pacifico L, Bonci E, et al. C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. Clin Chim Acta. 2011;412(11):1053–9.CrossRef
12.
go back to reference Schentag JJ, O’Keeffe D, Marmion M, Wels PB. C-reactive protein as an indicator of infection relapse in patients with abdominal sepsis. Arch Surg. 1984;119(3):300–4.CrossRef Schentag JJ, O’Keeffe D, Marmion M, Wels PB. C-reactive protein as an indicator of infection relapse in patients with abdominal sepsis. Arch Surg. 1984;119(3):300–4.CrossRef
13.
go back to reference Maury CP. Monitoring the acute phase response: comparison of tumour necrosis factor (cachectin) and C-reactive protein responses in inflammatory and infectious diseases. J Clin Pathol. 1989;42(10):1078–82.CrossRef Maury CP. Monitoring the acute phase response: comparison of tumour necrosis factor (cachectin) and C-reactive protein responses in inflammatory and infectious diseases. J Clin Pathol. 1989;42(10):1078–82.CrossRef
14.
go back to reference Povoa P, Almeida E, Moreira P, Fernandes A, Mealha R, Aragao A, et al. C-reactive protein as an indicator of sepsis. Intensive Care Med. 1998;24(10):1052–6.CrossRef Povoa P, Almeida E, Moreira P, Fernandes A, Mealha R, Aragao A, et al. C-reactive protein as an indicator of sepsis. Intensive Care Med. 1998;24(10):1052–6.CrossRef
15.
go back to reference Presterl E, Staudinger T, Pettermann M, Lassnigg A, Burgmann H, Winkler S, et al. Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. Am J Respir Crit Care Med. 1997;156(3 Pt 1):825–32.CrossRef Presterl E, Staudinger T, Pettermann M, Lassnigg A, Burgmann H, Winkler S, et al. Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. Am J Respir Crit Care Med. 1997;156(3 Pt 1):825–32.CrossRef
16.
go back to reference Yentis SM, Soni N, Sheldon J. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med. 1995;21(7):602–5.CrossRef Yentis SM, Soni N, Sheldon J. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med. 1995;21(7):602–5.CrossRef
17.
go back to reference Pinilla JC, Hayes P, Laverty W, Arnold C, Laxdal V. The C-reactive protein to prealbumin ratio correlates with the severity of multiple organ dysfunction. Surgery. 1998;124(4):799–805 (discussion-6).CrossRef Pinilla JC, Hayes P, Laverty W, Arnold C, Laxdal V. The C-reactive protein to prealbumin ratio correlates with the severity of multiple organ dysfunction. Surgery. 1998;124(4):799–805 (discussion-6).CrossRef
18.
go back to reference Waydhas C, Nast-Kolb D, Trupka A, Zettl R, Kick M, Wiesholler J, et al. Posttraumatic inflammatory response, secondary operations, and late multiple organ failure. J Trauma. 1996;40(4):624–30 (discussion 630-1).CrossRef Waydhas C, Nast-Kolb D, Trupka A, Zettl R, Kick M, Wiesholler J, et al. Posttraumatic inflammatory response, secondary operations, and late multiple organ failure. J Trauma. 1996;40(4):624–30 (discussion 630-1).CrossRef
19.
go back to reference Ikei S, Ogawa M, Yamaguchi Y. Blood concentrations of polymorphonuclear leucocyte elastase and interleukin-6 are indicators for the occurrence of multiple organ failures at the early stage of acute pancreatitis. J Gastroenterol Hepatol. 1998;13(12):1274–83.CrossRef Ikei S, Ogawa M, Yamaguchi Y. Blood concentrations of polymorphonuclear leucocyte elastase and interleukin-6 are indicators for the occurrence of multiple organ failures at the early stage of acute pancreatitis. J Gastroenterol Hepatol. 1998;13(12):1274–83.CrossRef
20.
go back to reference de Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KC. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg. 1996;83(3):349–53.CrossRef de Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KC. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg. 1996;83(3):349–53.CrossRef
21.
go back to reference Rau B, Steinbach G, Baumgart K, Gansauge F, Grunert A, Beger HG. Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant. Crit Care Med. 2000;28(3):736–42.CrossRef Rau B, Steinbach G, Baumgart K, Gansauge F, Grunert A, Beger HG. Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant. Crit Care Med. 2000;28(3):736–42.CrossRef
22.
go back to reference Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med. 2010;38(2 Suppl):S26–34.CrossRef Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med. 2010;38(2 Suppl):S26–34.CrossRef
23.
go back to reference van der Poll T, Levi M. Crosstalk between inflammation and coagulation: the lessons of sepsis. Curr Vasc Pharmacol. 2012;10(5):632–8.CrossRef van der Poll T, Levi M. Crosstalk between inflammation and coagulation: the lessons of sepsis. Curr Vasc Pharmacol. 2012;10(5):632–8.CrossRef
24.
go back to reference Berends ET, Kuipers A, Ravesloot MM, Urbanus RT, Rooijakkers SH. Bacteria under stress by complement and coagulation. FEMS Microbiol Rev. 2014;38(6):1146–71.CrossRef Berends ET, Kuipers A, Ravesloot MM, Urbanus RT, Rooijakkers SH. Bacteria under stress by complement and coagulation. FEMS Microbiol Rev. 2014;38(6):1146–71.CrossRef
25.
go back to reference Pahlman LI, Morgelin M, Kasetty G, Olin AI, Schmidtchen A, Herwald H. Antimicrobial activity of fibrinogen and fibrinogen-derived peptides—a novel link between coagulation and innate immunity. Thromb Haemost. 2013;109(5):930–9.CrossRef Pahlman LI, Morgelin M, Kasetty G, Olin AI, Schmidtchen A, Herwald H. Antimicrobial activity of fibrinogen and fibrinogen-derived peptides—a novel link between coagulation and innate immunity. Thromb Haemost. 2013;109(5):930–9.CrossRef
26.
go back to reference Senior RM, Skogen WF, Griffin GL, Wilner GD. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J Clin Invest. 1986;77(3):1014–9.CrossRef Senior RM, Skogen WF, Griffin GL, Wilner GD. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J Clin Invest. 1986;77(3):1014–9.CrossRef
27.
go back to reference Lauterbach R, Pawlik D, Radziszewska R, Wozniak J, Rytlewski K. Plasma antithrombin III and protein C levels in early recognition of late-onset sepsis in newborns. Eur J Pediatr. 2006;165(9):585–9.CrossRef Lauterbach R, Pawlik D, Radziszewska R, Wozniak J, Rytlewski K. Plasma antithrombin III and protein C levels in early recognition of late-onset sepsis in newborns. Eur J Pediatr. 2006;165(9):585–9.CrossRef
28.
go back to reference Semeraro F, Colucci M, Caironi P, Masson S, Ammollo CT, Teli R, et al. Platelet drop and fibrinolytic shutdown in patients with sepsis. Crit Care Med. 2018;46(3):e221–8.CrossRef Semeraro F, Colucci M, Caironi P, Masson S, Ammollo CT, Teli R, et al. Platelet drop and fibrinolytic shutdown in patients with sepsis. Crit Care Med. 2018;46(3):e221–8.CrossRef
29.
go back to reference Esmon CT. The interactions between inflammation and coagulation. Br J Haematol. 2005;131(4):417–30.CrossRef Esmon CT. The interactions between inflammation and coagulation. Br J Haematol. 2005;131(4):417–30.CrossRef
30.
go back to reference Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974;19(6):716–23.CrossRef Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974;19(6):716–23.CrossRef
31.
go back to reference Ersoy B, Nehir H, Altinoz S, Yilmaz O, Dundar PE, Aydogan A. Prognostic value of initial antithrombin levels in neonatal sepsis. Indian Pediatr. 2007;44(8):581–4.PubMed Ersoy B, Nehir H, Altinoz S, Yilmaz O, Dundar PE, Aydogan A. Prognostic value of initial antithrombin levels in neonatal sepsis. Indian Pediatr. 2007;44(8):581–4.PubMed
32.
go back to reference Taylor FB Jr, Kinasewitz GT, Lupu F. Pathophysiology, staging and therapy of severe sepsis in baboon models. J Cell Mol Med. 2012;16(4):672–82.CrossRef Taylor FB Jr, Kinasewitz GT, Lupu F. Pathophysiology, staging and therapy of severe sepsis in baboon models. J Cell Mol Med. 2012;16(4):672–82.CrossRef
33.
go back to reference Luo D, Szaba FM, Kummer LW, Plow EF, Mackman N, Gailani D, et al. Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor XI, during defense against the gram-negative bacterium Yersinia enterocolitica. J Immunol. 2011;187(4):1866–76.CrossRef Luo D, Szaba FM, Kummer LW, Plow EF, Mackman N, Gailani D, et al. Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor XI, during defense against the gram-negative bacterium Yersinia enterocolitica. J Immunol. 2011;187(4):1866–76.CrossRef
34.
go back to reference Mullarky IK, Szaba FM, Berggren KN, Parent MA, Kummer LW, Chen W, et al. Infection-stimulated fibrin deposition controls hemorrhage and limits hepatic bacterial growth during listeriosis. Infect Immun. 2005;73(7):3888–95.CrossRef Mullarky IK, Szaba FM, Berggren KN, Parent MA, Kummer LW, Chen W, et al. Infection-stimulated fibrin deposition controls hemorrhage and limits hepatic bacterial growth during listeriosis. Infect Immun. 2005;73(7):3888–95.CrossRef
35.
go back to reference Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol. 2012;34(1):43–62.CrossRef Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol. 2012;34(1):43–62.CrossRef
36.
go back to reference McAdow M, Missiakas DM, Schneewind O. Staphylococcus aureus secretes coagulase and von Willebrand factor binding protein to modify the coagulation cascade and establish host infections. J Innate Immun. 2012;4(2):141–8.CrossRef McAdow M, Missiakas DM, Schneewind O. Staphylococcus aureus secretes coagulase and von Willebrand factor binding protein to modify the coagulation cascade and establish host infections. J Innate Immun. 2012;4(2):141–8.CrossRef
37.
go back to reference Jennewein C, Mehring M, Tran N, Paulus P, Ockelmann PA, Habeck K, et al. The fibrinopeptide bbeta15–42 reduces inflammation in mice subjected to polymicrobial sepsis. Shock. 2012;38(3):275–80.CrossRef Jennewein C, Mehring M, Tran N, Paulus P, Ockelmann PA, Habeck K, et al. The fibrinopeptide bbeta15–42 reduces inflammation in mice subjected to polymicrobial sepsis. Shock. 2012;38(3):275–80.CrossRef
38.
go back to reference Wolf T, Kann G, Becker S, Stephan C, Brodt HR, de Leuw P, et al. Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care. Lancet. 2015;385(9976):1428–35.CrossRef Wolf T, Kann G, Becker S, Stephan C, Brodt HR, de Leuw P, et al. Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care. Lancet. 2015;385(9976):1428–35.CrossRef
39.
go back to reference Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, et al. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Am J Hematol. 2003;72(1):1–7.CrossRef Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, et al. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Am J Hematol. 2003;72(1):1–7.CrossRef
40.
go back to reference Renckens R, Roelofs JJ, Stegenga ME, Florquin S, Levi M, Carmeliet P, et al. Transgenic tissue-type plasminogen activator expression improves host defense during Klebsiella pneumonia. J Thromb Haemost. 2008;6(4):660–8.CrossRef Renckens R, Roelofs JJ, Stegenga ME, Florquin S, Levi M, Carmeliet P, et al. Transgenic tissue-type plasminogen activator expression improves host defense during Klebsiella pneumonia. J Thromb Haemost. 2008;6(4):660–8.CrossRef
41.
go back to reference Asakura H, Ontachi Y, Mizutani T, Kato M, Saito M, Kumabashiri I, et al. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation. Crit Care Med. 2001;29(6):1164–8.CrossRef Asakura H, Ontachi Y, Mizutani T, Kato M, Saito M, Kumabashiri I, et al. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation. Crit Care Med. 2001;29(6):1164–8.CrossRef
42.
go back to reference Mihajlovic D, Lendak D, Mitic G, Cebovic T, Draskovic B, Novakov A, et al. Prognostic value of hemostasis-related parameters for prediction of organ dysfunction and mortality in sepsis. Turk J Med Sci. 2015;45(1):93–8.CrossRef Mihajlovic D, Lendak D, Mitic G, Cebovic T, Draskovic B, Novakov A, et al. Prognostic value of hemostasis-related parameters for prediction of organ dysfunction and mortality in sepsis. Turk J Med Sci. 2015;45(1):93–8.CrossRef
43.
go back to reference Semeraro N, Ammollo CT, Semeraro F, Colucci M. Coagulopathy of acute sepsis. Semin Thromb Hemost. 2015;41(6):650–8.CrossRef Semeraro N, Ammollo CT, Semeraro F, Colucci M. Coagulopathy of acute sepsis. Semin Thromb Hemost. 2015;41(6):650–8.CrossRef
44.
go back to reference Parker RI. Coagulopathies in the PICU: DIC and liver disease. Crit Care Clin. 2013;29(2):319–33.CrossRef Parker RI. Coagulopathies in the PICU: DIC and liver disease. Crit Care Clin. 2013;29(2):319–33.CrossRef
45.
go back to reference Nesseler N, Launey Y, Aninat C, Morel F, Malledant Y, Seguin P. Clinical review: the liver in sepsis. Crit Care. 2012;16(5):235.CrossRef Nesseler N, Launey Y, Aninat C, Morel F, Malledant Y, Seguin P. Clinical review: the liver in sepsis. Crit Care. 2012;16(5):235.CrossRef
46.
go back to reference Ostrowski SR, Haase N, Muller RB, Moller MH, Pott FC, Perner A, et al. Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: a prospective study. Crit Care. 2015;19(191):015–0918. Ostrowski SR, Haase N, Muller RB, Moller MH, Pott FC, Perner A, et al. Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: a prospective study. Crit Care. 2015;19(191):015–0918.
47.
go back to reference Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood. 1992;80(8):1998–2005.PubMed Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood. 1992;80(8):1998–2005.PubMed
48.
go back to reference Yeaman MR. Platelets in defense against bacterial pathogens. Cell Mol Life Sci. 2010;67(4):525–44.CrossRef Yeaman MR. Platelets in defense against bacterial pathogens. Cell Mol Life Sci. 2010;67(4):525–44.CrossRef
49.
go back to reference Clemetson KJ. The role of platelets in defence against pathogens. Hamostaseologie. 2011;31(4):264–8.CrossRef Clemetson KJ. The role of platelets in defence against pathogens. Hamostaseologie. 2011;31(4):264–8.CrossRef
50.
go back to reference Saloga J, Klimek L, Buhl R, Mann W, Knop J, Grabbe S. Allergologie-Handbuch: Grundlagen und klinische Praxis. Stuttgart: Schattauer Verlag; 2012. Saloga J, Klimek L, Buhl R, Mann W, Knop J, Grabbe S. Allergologie-Handbuch: Grundlagen und klinische Praxis. Stuttgart: Schattauer Verlag; 2012.
51.
go back to reference Taori RN, Lahiri KR, Tullu MS. Performance of PRISM (pediatric risk of mortality) score and PIM (pediatric index of mortality) score in a tertiary care pediatric ICU. Indian J Pediatr. 2010;77(3):267–71.CrossRef Taori RN, Lahiri KR, Tullu MS. Performance of PRISM (pediatric risk of mortality) score and PIM (pediatric index of mortality) score in a tertiary care pediatric ICU. Indian J Pediatr. 2010;77(3):267–71.CrossRef
52.
go back to reference Kutko MC, Calarco MP, Flaherty MB, Helmrich RF, Ushay HM, Pon S, et al. Mortality rates in pediatric septic shock with and without multiple organ system failure. Pediatr Crit Care Med. 2003;4(3):333–7.CrossRef Kutko MC, Calarco MP, Flaherty MB, Helmrich RF, Ushay HM, Pon S, et al. Mortality rates in pediatric septic shock with and without multiple organ system failure. Pediatr Crit Care Med. 2003;4(3):333–7.CrossRef
53.
go back to reference Hatherill M, Tibby SM, Turner C, Ratnavel N, Murdoch IA. Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit Care Med. 2000;28(7):2591–4.CrossRef Hatherill M, Tibby SM, Turner C, Ratnavel N, Murdoch IA. Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit Care Med. 2000;28(7):2591–4.CrossRef
54.
go back to reference Wilkinson JD, Pollack MM, Ruttimann UE, Glass NL, Yeh TS. Outcome of pediatric patients with multiple organ system failure. Crit Care Med. 1986;14(4):271–4.CrossRef Wilkinson JD, Pollack MM, Ruttimann UE, Glass NL, Yeh TS. Outcome of pediatric patients with multiple organ system failure. Crit Care Med. 1986;14(4):271–4.CrossRef
Metadata
Title
Inflammatory and coagulatory parameters linked to survival in critically ill children with sepsis
Authors
Christian Niederwanger
Mirjam Bachler
Tobias Hell
Caroline Linhart
Andreas Entenmann
Agnes Balog
Katharina Auer
Petra Innerhofer
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Annals of Intensive Care / Issue 1/2018
Electronic ISSN: 2110-5820
DOI
https://doi.org/10.1186/s13613-018-0457-8

Other articles of this Issue 1/2018

Annals of Intensive Care 1/2018 Go to the issue